Products In Development

We have several unique products in development.

  • Romeg’s pipeline efforts focus on targeting high unmet needs, orphan indications in rheumatologic and cardiac inflammatory diseases 
  • Our development is focused on reformulating well-characterized molecules into innovative new formulations to address opportunities historically overlooked by the pharmaceutical industry 
  • Pipeline programs are characterized by a derisked development pathway and well-characterized commercial opportunity
Sjogren’s-disease

Spotlight on Sjögren’s disease

  • Sjögren’s Disease is a systemic autoimmune disease that affects the entire body
  • Many patients experience dry eyes, dry mouth, fatigue and joint pain
  • Other serious complications include dysfunction of major organs, neuropathies, and lymphomas
  • Early diagnosis and proper treatments are important as they may prevent serious complications and greatly improve a patient’s quality of life
  • About half of the time Sjögren’s occurs alone, and the other half it occurs in the presence of another autoimmune connective tissue disease such as Rheumatoid Arthritis, Lupus, or Scleroderma
  • Sjögren’s is often misrepresented as a rare disease, however it is estimated that there are four million Americans living with this disease, making it one of the most prevalent autoimmune diseases

For more information, visit the Sjögren’s Foundation website

ROMEG Pipeline